Vaping, environmental toxicants exposure, and lung cancer risk

SA Shehata, EA Toraih, EA Ismail, AM Hagras… - Cancers, 2023 - mdpi.com
Simple Summary Lung cancer (LC) is considered one of the most common cancers globally.
Numerous studies have determined the relations between E-cigarette, or vaping, products …

Small cell lung carcinoma: current diagnosis, biomarkers, and treatment options with future perspectives

K Krpina, S Vranić, K Tomić, M Samaržija, L Batičić - Biomedicines, 2023 - mdpi.com
Small cell lung cancer (SCLC) is an aggressive malignancy characterized by rapid
proliferation, early dissemination, acquired therapy resistance, and poor prognosis. Early …

Association between blood heavy metals and lung cancer risk: A case-control study in China

K Zhang, T Zhu, X Quan, Y Qian, Y Liu, J Zhang… - Chemosphere, 2023 - Elsevier
Background Exposure to various metals has been reported to lead to lung cancer. However,
few studies focused on the combined effects of metal mixture. Objective To explore the …

Gender disparities in lung cancer incidence in the United States during 2001–2019

Y Fu, J Liu, Y Chen, Z Liu, H Xia, H Xu - Scientific Reports, 2023 - nature.com
Lung cancer ranks as one of the top malignancies and the leading cause of cancer death in
both males and females in the US. Using a cancer database covering the entire population …

Updates on lung neuroendocrine neoplasm classification

G Vocino Trucco, L Righi, M Volante… - Histopathology, 2024 - Wiley Online Library
Lung neuroendocrine neoplasms (NENs) are a heterogeneous group of pulmonary
neoplasms showing different morphological patterns and clinical and biological …

Unlocking New Horizons in Small-Cell Lung Cancer Treatment: The Onset of Antibody–Drug Conjugates

L Belluomini, M Sposito, A Avancini, J Insolda… - Cancers, 2023 - mdpi.com
Simple Summary Small-cell lung cancer (SCLC) represents a highly aggressive form of lung
cancer. Although SCLC initially responds to chemoimmunotherapy, it inevitably relapses …

Small-Cell Lung Cancer: Is Liquid Biopsy a New Tool Able to Predict the Efficacy of Immunotherapy?

R Fasano, S Serratì, T Rafaschieri, V Longo, R Di Fonte… - Biomolecules, 2024 - mdpi.com
Small-cell lung cancer (SCLC) cases represent approximately 15% of all lung cancer cases,
remaining a recalcitrant malignancy with poor survival and few treatment options. In the last …

The changing landscape of small cell lung cancer

GF Cittolin‐Santos, B Knapp, B Ganesh, F Gao… - Cancer, 2024 - Wiley Online Library
Background Small‐cell lung cancer (SCLC) is characterized by rapid proliferation and early
dissemination. The objective of this study was to examine the demographic trends and …

ELAVL4 promotes the tumorigenesis of small cell lung cancer by stabilizing LncRNA LYPLAL1‐DT and enhancing profilin 2 activation

S Li, J Lv, X Zhang, Q Zhang, Z Li, J Lu… - The FASEB …, 2023 - Wiley Online Library
Small cell lung cancer (SCLC) is one of the most malignant tumors that has an extremely
poor prognosis. RNA‐binding protein (RBP) and long noncoding RNA (lncRNA) have been …

Deciphering the role of immunoglobulin secreting malignant lineages in the invasive frontiers of small cell lung cancer by scRNA-seq and spatial transcriptomics …

F Wu, X Zhang, M Wang, J Zhang, M Chen, Z Ren… - Cell Discovery, 2023 - nature.com
Dear Editor, Lung cancer remains the leading cause of cancer-related death worldwide 1.
Small cell lung cancer (SCLC) comprises~ 14% of lung cancer and causes 200,000 deaths …